Volume 4 Number 1 May 2008

Today Europe, tomorrow the world!

• Serruys PW

EuroInterv.2008;4:15

Percutaneous Cardiovascular Intervention. The time has come for a big change...

• Wijns W

EuroInterv.2008;4:17-21

Chronic total coronary occlusions and the Occluded Artery Trial. A critical appraisal.

• Werner G,
• Di Mario C,
• Galassi A,
• Gershlick A,
• Reimers B,
• Sianos G,
• Sievert H,
• Lefèvre T,
• Reifart N

EuroInterv.2008;4:23-27

Last nail in the coffin of late lumen loss?

• Biondi-Zoccai G,
• Agostoni P,
• Sheiban I

EuroInterv.2008;4:29-32

Together we achieve more...

• Wijns W,
• Marco J,
• Doncieux M

EuroInterv.2008;4:33-35

Why don't we return to bare metal stents?

• Hess O,
• Karjalainen P,
• Wallentin S,
• de Winter R

EuroInterv.2008;4:36-41

Why we should never return to bare metal stents?

• Morice M-C,
• Thomas M,
• Buellesfeld L,
• Grube E,
• Colombo A

EuroInterv.2008;4:42-46

Cardiovascular repair and regeneration 2008: the Fourth International Conference on Cell Therapy for Cardiovascular Disease (IC3D)

• Sherman W,
• Dimmeler S,
• Hare J,
• Penn M

EuroInterv.2008;4:47-49

Highlights from ICI-Innovations in Cardiovascular Interventions. December 3-5, 2007, Tel Aviv, Israel

• Beyar R,
• Lotan C

EuroInterv.2008;4:50-52

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

• Costa Júnior J,
• Abizaid A,
• Feres F,
• Costa R,
• Seixas A,
• Maia F,
• Abizaid An,
• Tanajura L,
• Staico R,
• Siqueira D,
• Meredith L,
• Bhat V,
• Yan J,
• Ormiston J,
• Sousa A,
• Fitzgerald P,
• Sousa J

EuroInterv.2008;4:53-58

Biodegradable-polymer-based, sirolimus-eluting Supralimus® stent: 6-month angiographic and 30 month clinical follow-up results from the Series I prospective study

• Dani S,
• Kukreja N,
• Parikh P,
• Joshi H,
• Prajapati J,
• Jain S,
• Thanvi S,
• Shah B,
• Dutta J-P

EuroInterv.2008;4:59-63

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study

• Dirksen M,
• Vink M,
• Suttorp M,
• Tijssen J,
• Patterson M,
• Slagboom T,
• Kiemeneij F,
• Laarman GJ

EuroInterv.2008;4:64-70

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results

• Grube E,
• Sievert H,
• Hauptmann K-E,
• Mueller R,
• Gerckens U,
• Buellesfeld L,
• Ako J,
• Shimohama T,
• Costa M,
• Fitzgerald P

EuroInterv.2008;4:71-76

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

• Meliga E,
• García-García HM,
• Valgimigli M,
• Chieffo A,
• Biondi-Zoccai G,
• O’ Maree A,
• Gonzalo N,
• Cook S,
• Cruz-Gonzalez I,
• Marra S,
• De Servi S,
• Palacios I,
• Windecker S,
• van Domburg R,
• Colombo A,
• Sheiban I,
• Serruys PW

EuroInterv.2008;4:77-83

European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the EuroCTO club

• Sianos G,
• Barlis P,
• Di Mario C,
• Papafaklis M,
• Büttner J,
• Galassi A,
• Schofer J,
• Werner G,
• Lefèvre T,
• Louvard Y,
• Serruys PW,
• Reifart N

EuroInterv.2008;4:84-92

Impact of bifurcation lesions on clinical outcome and prognosis of primary angioplasty in acute myocardial infarction

• Abdel Hakim D-E,
• Garot P,
• Champagne S,
• Maklady F,
• El Hawary A,
• Dubois-Randé J-L,
• Lesault P-F,
• Teiger E

EuroInterv.2008;4:93-98

Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results

• Meliga E,
• Vranckx P,
• Regar E,
• Kint P-P,
• Duncker D,
• Serruys PW

EuroInterv.2008;4:99-107

Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions

• Assali A,
• Raz Y,
• Vaknin-Assa H,
• Ben-Dor I,
• Brosh D,
• Teplitsky I,
• Fuchs S,
• Kornowski R

EuroInterv.2008;4:108-114

The role of thrombectomy and distal protection devices during percutaneous coronary interventions

• Mamas M,
• Fraser D,
• Fath-Ordoubadi F

EuroInterv.2008;4:115-123

Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents

• Rivero F,
• Moreno R,
• Barreales L,
• Galeote G,
• Sánchez-Recalde A,
• Calvo L,
• Jimenez-Valero S,
• Villate A,
• Vanegas M,
• López-Sendón J-L

EuroInterv.2008;4:124-132

Recovery and functional activity of mononuclear bone marrow and peripheral blood cells after different cell isolation protocols used in clinical trials for cell therapy after acute myocardial infarction

• van Beem R,
• Hirsch A,
• Lommerse I,
• Zwaginga J,
• Noort W,
• Biemond B,
• Piek J,
• van der Schoot C,
• Voermans C

EuroInterv.2008;4:133-138

The neointimal response to stents eluting Tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release

• van Beusekom H,
• Sorop O,
• Weymaere M,
• Duncker D,
• van der Giessen WJ

EuroInterv.2008;4:139-147

Percutaneous aortic valve implantation utilising a novel tissue valve: preclinical experience

• Bolling S,
• Rogers J,
• Babaliaros V,
• Piazza N,
• Takeda P,
• Low R,
• Block P

EuroInterv.2008;4:148-153

Development of IMRISCardio™, an integrated, interventional angio-MR Imaging Suite

• Ede M,
• Saunders J

EuroInterv.2008;4:154-157

Medical positioning system: a technical report

• Flugelman M,
• Shiran A,
• Nusimovici-Avadis D,
• Schwartz L,
• Herscovici A,
• Cohen A,
• Shofti R,
• Lewis B,
• Luchner A,
• Jeron A

EuroInterv.2008;4:158-160

HBOC-201: The multi-purpose oxygen therapeutic

• Dubé G,
• Vranckx P,
• Greenburg A

EuroInterv.2008;4:161-165